Skip to main content
. 2008 Apr 3;111(12):5477–5485. doi: 10.1182/blood-2008-01-132837

Figure 5.

Figure 5

Prognostic significance of day-8 blood MRD in patients who are free of MRD in bone marrow by day 29. Patients with high levels (defined as > 1%) MRD at day 8 fare worse (5-year EFS of 79% ± 4%) than those with lower levels (90% ± 1%), even if they become MRD by day 29. This difference was especially important in NCI HR patients (see “Results”).